Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig. - nonacog alfa (factor ix recombinante) - nonacog alfa (factor ix recombinante)....250 ui/ vial / cloruro de sodio....0,234%

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig - nonacog alfa (factor ix recombinante) - nonacog alfa (factor ix recombinante)....500 mg / cloruro de sodio....0,234%

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - eftrenonacog alfa 4000 [iu];   - powder for infusion - 4000 iu - active: eftrenonacog alfa 4000 [iu]   excipient: histidine hydrochloric acid mannitol polysorbate 20 sucrose sodium chloride water for injection - alprolix is a long-acting anti-haemophilic factor (recombinant) indicated in adults and children with haemophilia b (congenital factor ix deficiency) for: - control and prevention of bleeding episodes - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - perioperative management (surgical prophylaxis)

Kenya - English - Pharmacy and Poisons Board

nonacog alfa - powder and solvent for solution for injection - 1000 iu - nonacog alfa

Kenya - English - Pharmacy and Poisons Board

nonacog alfa - powder and solution for solution for injectio - 250 iu - nonacog alfa

Kenya - English - Pharmacy and Poisons Board

nonacog alfa - powder and solvent for solution for injection - 500 iu - nonacog alfa

Panama - English - Ministerio de Salud (Dirección Nacional de Farmacia Y Drogas)

pfizer europe ma eeig - nonacog alfa (factor ix recombinante) - nonacog alfa (factor ix recombinante)....1000 ui / cloruro de sodio al 0.234 %....11,93 mg

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 1000 [iu];  ;   - powder for injection - 1000 iu - active: albutrepenonacog alfa 1000 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 2000 [iu];  ;   - powder for injection - 2000 iu - active: albutrepenonacog alfa 2000 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.

New Zealand - English - Medsafe (Medicines Safety Authority)

csl behring (nz) ltd - albutrepenonacog alfa 250 [iu];  ;   - powder for injection - 250 iu - active: albutrepenonacog alfa 250 [iu]     excipient: hydrochloric acid mannitol polysorbate 80 sodium citrate dihydrate sucrose water for injection - idelvion is indicated in all patients with haemophilia b for: - routine prophylaxis to prevent or reduce the frequency of bleeding episodes - control and prevention of bleeding episodes - control and prevention of bleeding in the perioperative setting.